Congressional Pressure on Feds to Speed up Medical Marijuana Research Work

The marijuana topic is one of the never-ending discussions that keep on going to the United States. In a recent meeting, a 30 member’s congressional bipartisan group has asked the Attorneys to look into the matter of Medical Marijuana as soon as possible. This is not the first time when a group is asking for […]

Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells

Teresa Iuvone 1, Giuseppe Esposito, Ramona Esposito, Rita Santamaria, Massimo Di Rosa, Angelo A Izzo Alzheimer’s disease is widely held to be associated with oxidative stress due, in part, to the membrane action of beta-amyloid peptide aggregates. Here, we studied the effect of cannabidiol, a major non-psychoactive component of the marijuana plant (Cannabis sativa) on beta-amyloid peptide-induced toxicity in cultured rat […]

A Review on Studies of Marijuana for Alzheimer’s Disease – Focusing on CBD, THC

Seok Hee Kim,1Jin Won Yang,2Kyung Han Kim,3Jong Uk Kim,1 and  Tae Han Yook1,* Published online 2019 Dec 31. doi: 10.3831/KPI.2019.22.030 The interest in senile disease is rising gradually because aging society has become a more common phenomenon. Types of dementia include AD, vascular dementia, paralytic dementia, Lewy body dementia, carbon monoxide induced dementia, and trauma dementia [1,2]. The onset […]

Cannabinoids in the Treatment of Neurological Disorders

Orrin Devinsky,Benjamin J. Whalley, and  Vincenzo Di Marzo Neurotherapeutics. 2015 September 23; 12(4): 910. “… “…Dronabinol (Marinol) is the only cannabinoid-based medicine that is approved by the US Food and Drug Administration, with an indication for loss of appetite associated with weight loss in patients with AIDS and those receiving chemotherapy [2]. Dronabinol is the synthetic active […]

San Diego VA study testing cannabidiol—a compound derived from cannabis—for PTSD

February 5, 2019 By Mitch Mirkin VA Research Communications San Diego VA study testing cannabidiol—a compound derived from cannabis—for PTSD  Office of Research & Development Researchers at the VA San Diego Healthcare System aim to see whether cannabidiol, or CBD—a compound derived from cannabis plants—can help ease PTSD. The study will give CBD as an add-on […]

WHO report: CBD has a “good safety profile” and “may be a useful treatment.”

Malayka Gormally May 28, 2018 The World Health Organization (WHO) in a November 2017 report concluded that “CBD is generally well tolerated with a good safety profile. Reported adverse effects may be as a result of drug interactions between CBD and patients’ existing medications. Several countries have modified their national controls to accommodate CBD as […]

Clinical trial for a CBD pill for concussions

Concussion AllianceAugust 19, 2018 The first US-based clinical trial on CBD treatment for concussion is being conducted by the University of Miami. The five-year, three-stage study is funded by a $16 million grant from Canadian company Scythian Biosciences. The clinical trial will conduct research on a pill that combines CBD and dexanabiol, which researchers believe will reduce brain […]

VA Policy On Medical Marijuana and Veterans

“Veterans Will Not Lose VA Benefits For Discussing Medical Marijuana With VA Care Providers” “…The VA official site makes it clear that veterans who use cannabis, pot, 420, etc… are not in danger of losing VA benefits: Veteran participation in state marijuana programs does not affect eligibility for VA care and services. VA providers can and do […]

CBD DOSING

High dose? Low dose? CBD? THC? Optimizing your medical use of cannabis may entail some experimentation. By Martin A. Lee on May 16, 2018 (Updated on April 1, 2019) It can be relatively easy to experience medical benefits from cannabis. A puff or two of tetrahydrocannabinol (THC)-rich flower can do the trick for a lot of people. Smoking […]